Nanjing Vazyme Biotech Co., Ltd

¥22.22As of Sun 8 Nov 2026, 12:00 UTC
SSE:688105Healthcare
Country China
PE (Fwd) •••
TSR 5Y CAGR (23.33%)
Div yield 1.73%
ROE (0.26%)
Biotechnology
Beta (5Y) 0.70
PE TTM 14,647
TSR TTM 26.23%
Mkt cap ¥11.49B
ROIC (3.55%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
¥28
25.40%
346.56%
Buy 11|8|10|3|5
4Q25
1Q26
2Q26
3Q26
Earnings per share¥
0.52
0.56
0.63
0.68
15.85%
30.01%
44.02%
42.87%
Revenue¥M
633.8
618.3
634.7
627.2
9.06%
3.17%
1.48%
(3.32%)
Peers (US$1.722B)
Cap (US$)
PE
1.713B
—
1.646B
17.38x
Capital
TTM
5Y
10Y
Leveragex
0.974
0.300
0.206
EBIT/Intx
1.507
0.677
0.523
Own earn%
(77.91)
40.99
44.32
Sh yield%
29.99
11.15
6.82
Owners
Insiders/Inst%
4.85
63.30
Short interest%
0.95
SBC / revenue%
3.68
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
6
Op margin range%
0–6
$1 testx
0.1
Incr. ROIC%
5